CR20190006A - Composición y aposito para tratamiento de heridas - Google Patents
Composición y aposito para tratamiento de heridasInfo
- Publication number
- CR20190006A CR20190006A CR20190006A CR20190006A CR20190006A CR 20190006 A CR20190006 A CR 20190006A CR 20190006 A CR20190006 A CR 20190006A CR 20190006 A CR20190006 A CR 20190006A CR 20190006 A CR20190006 A CR 20190006A
- Authority
- CR
- Costa Rica
- Prior art keywords
- contribution
- composition
- wound treatment
- compositions
- blood
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0004—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing inorganic materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/36—Blood coagulation or fibrinolysis factors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/36—Blood coagulation or fibrinolysis factors
- A61K38/363—Fibrinogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/07—Stiffening bandages
- A61L15/14—Use of materials characterised by their function or physical properties
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/18—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing inorganic materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/20—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing organic materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/44—Medicaments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0061—Use of materials characterised by their function or physical properties
- A61L26/0066—Medicaments; Biocides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- C—CHEMISTRY; METALLURGY
- C04—CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
- C04B—LIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
- C04B35/00—Shaped ceramic products characterised by their composition; Ceramics compositions; Processing powders of inorganic compounds preparatory to the manufacturing of ceramic products
- C04B35/01—Shaped ceramic products characterised by their composition; Ceramics compositions; Processing powders of inorganic compounds preparatory to the manufacturing of ceramic products based on oxide ceramics
- C04B35/16—Shaped ceramic products characterised by their composition; Ceramics compositions; Processing powders of inorganic compounds preparatory to the manufacturing of ceramic products based on oxide ceramics based on silicates other than clay
- C04B35/18—Shaped ceramic products characterised by their composition; Ceramics compositions; Processing powders of inorganic compounds preparatory to the manufacturing of ceramic products based on oxide ceramics based on silicates other than clay rich in aluminium oxide
- C04B35/185—Mullite 3Al2O3-2SiO2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/10—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing inorganic materials
- A61L2300/102—Metals or metal compounds, e.g. salts such as bicarbonates, carbonates, oxides, zeolites, silicates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/252—Polypeptides, proteins, e.g. glycoproteins, lipoproteins, cytokines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/402—Anaestetics, analgesics, e.g. lidocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/418—Agents promoting blood coagulation, blood-clotting agents, embolising agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/45—Mixtures of two or more drugs, e.g. synergistic mixtures
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2400/00—Materials characterised by their function or physical properties
- A61L2400/04—Materials for stopping bleeding
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/745—Blood coagulation or fibrinolysis factors
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Materials Engineering (AREA)
- Hematology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Inorganic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Ceramic Engineering (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Structural Engineering (AREA)
- Manufacturing & Machinery (AREA)
- Diabetes (AREA)
- Dermatology (AREA)
- Medicinal Preparation (AREA)
- Materials For Medical Uses (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
La invención proporciona métodos y composiciones para el tratamiento de heridas y/o la formación de coágulo de sangre, por ejemplo, al detener el flujo de sangre desde una herida abierta. Los métodos y composiciones proporcionan la promoción y aceleración de la sanación de herida y opcionalmente proporcionan la inhibición de infección microbiana y/o un efecto analgésico local.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201161533484P | 2011-09-12 | 2011-09-12 | |
US201261670251P | 2012-07-11 | 2012-07-11 | |
PCT/US2012/054928 WO2013040080A1 (en) | 2011-09-12 | 2012-09-12 | Composition and dressing for wound treatment |
Publications (1)
Publication Number | Publication Date |
---|---|
CR20190006A true CR20190006A (es) | 2019-03-18 |
Family
ID=47883695
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CR20190006A CR20190006A (es) | 2011-09-12 | 2012-09-12 | Composición y aposito para tratamiento de heridas |
CR20140119A CR20140119A (es) | 2011-09-12 | 2014-03-11 | Composición y apósito para tratamiento de heridas |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CR20140119A CR20140119A (es) | 2011-09-12 | 2014-03-11 | Composición y apósito para tratamiento de heridas |
Country Status (12)
Country | Link |
---|---|
US (2) | US9408913B2 (es) |
EP (2) | EP2755676B1 (es) |
CN (1) | CN104023741B (es) |
BR (1) | BR112014005597B1 (es) |
CA (1) | CA2848351A1 (es) |
CR (2) | CR20190006A (es) |
ES (1) | ES2753234T3 (es) |
HK (1) | HK1200319A1 (es) |
IL (1) | IL231454B (es) |
MX (1) | MX351641B (es) |
SG (1) | SG11201502833RA (es) |
WO (1) | WO2013040080A1 (es) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0808376D0 (en) | 2008-05-08 | 2008-06-18 | Bristol Myers Squibb Co | Wound dressing |
GB0817796D0 (en) | 2008-09-29 | 2008-11-05 | Convatec Inc | wound dressing |
GB201020236D0 (en) | 2010-11-30 | 2011-01-12 | Convatec Technologies Inc | A composition for detecting biofilms on viable tissues |
ES2748519T3 (es) | 2010-12-08 | 2020-03-17 | Convatec Technologies Inc | Accesorio de sistema de exudado de heridas |
WO2012078781A1 (en) | 2010-12-08 | 2012-06-14 | Convatec Technologies Inc. | Integrated system for assessing wound exudates |
GB201115182D0 (en) | 2011-09-02 | 2011-10-19 | Trio Healthcare Ltd | Skin contact material |
GB2497406A (en) | 2011-11-29 | 2013-06-12 | Webtec Converting Llc | Dressing with a perforated binder layer |
GB201120693D0 (en) | 2011-12-01 | 2012-01-11 | Convatec Technologies Inc | Wound dressing for use in vacuum therapy |
EP2935688A2 (en) | 2012-12-20 | 2015-10-28 | ConvaTec Technologies Inc. | Processing of chemically modified cellulosic fibres |
WO2015006299A1 (en) * | 2013-07-08 | 2015-01-15 | Imprimis Pharmaceuticals, Inc. | Pharmaceutical formulations of tranexamic acid and their use |
WO2015042104A1 (en) * | 2013-09-17 | 2015-03-26 | Biolife, L.L.C. | Improved adaptive devices and methods for endoscopic wound closures |
SG11201808488XA (en) | 2016-03-30 | 2018-10-30 | Convatec Technologies Inc | Detecting microbial infections in wounds |
KR20190008199A (ko) | 2016-03-30 | 2019-01-23 | 시노보 게엠베하 | 상처에서 미생물 감염의 검출 방법 |
US11596554B2 (en) | 2016-07-08 | 2023-03-07 | Convatec Technologies Inc. | Flexible negative pressure system |
BR112019000284A2 (pt) | 2016-07-08 | 2019-04-16 | Convatec Technologies Inc. | aparelho de coleta de fluido |
CA3030153C (en) | 2016-07-08 | 2023-10-24 | Convatec Technologies Inc. | Fluid flow sensing |
US11771819B2 (en) | 2019-12-27 | 2023-10-03 | Convatec Limited | Low profile filter devices suitable for use in negative pressure wound therapy systems |
US11331221B2 (en) | 2019-12-27 | 2022-05-17 | Convatec Limited | Negative pressure wound dressing |
US11654057B2 (en) | 2020-04-09 | 2023-05-23 | Bio 54, Llc | Devices for bleeding reduction and methods of making and using the same |
US11642324B1 (en) | 2022-03-01 | 2023-05-09 | Bio 54, Llc | Topical tranexamic acid compositions and methods of use thereof |
CN115410465B (zh) * | 2022-11-01 | 2023-02-03 | 世纪亿康(天津)医疗科技发展有限公司 | 一种用于模拟凝血过程的血液模拟液 |
Family Cites Families (42)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3113568A (en) | 1961-12-26 | 1963-12-10 | Eric K Erskine | Styptic bandage |
US4822349A (en) | 1984-04-25 | 1989-04-18 | Hursey Francis X | Method of treating wounds |
US5310420A (en) * | 1992-09-21 | 1994-05-10 | Precision Metalsmiths, Inc. | Refractory containing investment material and method of making |
ZA987019B (en) * | 1997-08-06 | 1999-06-04 | Focal Inc | Hemostatic tissue sealants |
US5955112A (en) | 1998-02-11 | 1999-09-21 | Kaplan; Jeffrey | Non-stinging styptic pencil |
US20070009586A1 (en) | 2000-02-29 | 2007-01-11 | Cohen Kelman I | Wound dressings containing complexes of transition metals and alginate for elastase sequestering |
KR100575113B1 (ko) | 2000-06-21 | 2006-05-03 | 가부시키가이샤 구라레 | 다공질 중공 섬유막 및 이의 제조방법 |
US20030165560A1 (en) | 2000-09-14 | 2003-09-04 | Shigenori Otsuka | Preparations for coating wound |
US6652840B1 (en) * | 2001-02-21 | 2003-11-25 | Terence Prevendar | Bleeding control and healing aid compositions and methods of use |
US6568398B2 (en) * | 2001-03-07 | 2003-05-27 | Edgar C. Cohen | Method for hemostasis |
US7942669B2 (en) | 2002-12-02 | 2011-05-17 | Centrix, Inc. | Gingival tissue retraction device and method |
US20050008583A1 (en) | 2003-07-11 | 2005-01-13 | Sander White | Material and system for gingival retraction and other applications |
WO2005027808A1 (en) | 2003-09-12 | 2005-03-31 | Z-Medica Corporation | Calcium zeolite hemostatic agent |
ATE489062T1 (de) | 2003-09-12 | 2010-12-15 | Z Medica Corp | Teilweise hydriertes hämostatisches mittel |
US8932632B2 (en) * | 2003-10-21 | 2015-01-13 | Ppg Industries Ohio, Inc. | Adhesives and sealants nanotechnology |
US20100069813A1 (en) | 2004-07-15 | 2010-03-18 | Crisp William E | Wound dressings |
CN101160143A (zh) * | 2005-02-15 | 2008-04-09 | 弗吉尼亚大学 | 用于急性止血、治疗急性损伤和慢性溃疡的矿物技术(mt) |
US7858123B2 (en) | 2005-04-04 | 2010-12-28 | The Regents Of The University Of California | Inorganic materials for hemostatic modulation and therapeutic wound healing |
ES2415362T3 (es) | 2005-04-08 | 2013-07-25 | Mie University | Agente externo para tratar heridas |
WO2007056671A1 (en) | 2005-11-02 | 2007-05-18 | Osteotech, Inc. | Hemostatic bone graft |
US20070154510A1 (en) | 2005-12-30 | 2007-07-05 | Wilcher Steve A | Adsorbent-Containing Hemostatic Devices |
GB0607438D0 (en) | 2006-04-13 | 2006-05-24 | Dow Corning | Water containing silicone rubber device, process to make the device and uses for it |
WO2007127390A2 (en) | 2006-04-28 | 2007-11-08 | Biolife, L.L.C. | Materials and methods for wound treatment |
FR2900824A1 (fr) * | 2006-05-10 | 2007-11-16 | Prod Dentaires Pierre Rolland | Pate destinee a arreter les saignements, ses utilisations, et seringue la contenant |
US7968114B2 (en) | 2006-05-26 | 2011-06-28 | Z-Medica Corporation | Clay-based hemostatic agents and devices for the delivery thereof |
US7604819B2 (en) | 2006-05-26 | 2009-10-20 | Z-Medica Corporation | Clay-based hemostatic agents and devices for the delivery thereof |
CN1970090B (zh) | 2006-09-14 | 2015-11-25 | 华东理工大学 | 纳米介孔硅基干凝胶止血材料及其制备方法和应用 |
US20080085300A1 (en) | 2006-10-06 | 2008-04-10 | Z-Medica Corporation | Hemostatic compositions and method of manufacture |
WO2008051513A2 (en) * | 2006-10-23 | 2008-05-02 | Allan Pronovost | Compositions and methods for treating lacerations, abrasions, avulsions, burns, ulcers, and cases of excessive bleeding |
WO2008127497A2 (en) | 2007-02-21 | 2008-10-23 | The Regents Of The University Of California | Hemostatic compositions and methods of use |
US20080220050A1 (en) * | 2007-03-08 | 2008-09-11 | Kerr Corporation | Compositions For Gingival Retraction And Other Methods |
WO2009023745A1 (en) | 2007-08-14 | 2009-02-19 | The Regents Of The University Of California | Mesocellular oxide foams as hemostatic compositions and methods of use |
US20090123509A1 (en) | 2007-11-08 | 2009-05-14 | Cory Berkland | Biodegradable Colloidal Gels as Moldable Tissue Engineering Scaffolds |
US8883194B2 (en) | 2007-11-09 | 2014-11-11 | Honeywell International, Inc. | Adsorbent-containing hemostatic devices |
US8319002B2 (en) | 2007-12-06 | 2012-11-27 | Nanosys, Inc. | Nanostructure-enhanced platelet binding and hemostatic structures |
DE102008005469A1 (de) | 2008-01-21 | 2009-07-23 | Kettenbach Gmbh & Co. Kg | Pastöses Einsetzmaterial zur Erweiterung des Zahnfleischsulcus und dessen Verwendung |
US20090235091A1 (en) * | 2008-02-14 | 2009-09-17 | Systems Associates, Inc. | Computer system for indexing and storing sensitive, secured, information on a non-trusted computer storage array |
US8795718B2 (en) | 2008-05-22 | 2014-08-05 | Honeywell International, Inc. | Functional nano-layered hemostatic material/device |
SE532493C2 (sv) | 2008-05-29 | 2010-02-09 | Moelnlycke Health Care Ab | Sårförband med två med varandra förbundna sårdynor,lämpligt för användning med kompressionsbandage |
SE0801490A0 (sv) | 2008-06-24 | 2009-12-25 | Moelnlycke Health Care Ab | Sårförband |
KR20120094896A (ko) * | 2009-07-06 | 2012-08-27 | 몰리코프 미네랄스, 엘엘씨 | 상처 드레싱에서 항균 장벽 및 살균제로 이용되는 세리아 |
US20110262518A1 (en) * | 2010-04-27 | 2011-10-27 | Smyth Stuart K J | Treatment for cardiac injuries created by myocardial infarction |
-
2012
- 2012-09-12 CA CA2848351A patent/CA2848351A1/en not_active Abandoned
- 2012-09-12 US US14/344,403 patent/US9408913B2/en active Active
- 2012-09-12 EP EP12832223.7A patent/EP2755676B1/en not_active Not-in-force
- 2012-09-12 CR CR20190006A patent/CR20190006A/es unknown
- 2012-09-12 BR BR112014005597-1A patent/BR112014005597B1/pt not_active IP Right Cessation
- 2012-09-12 MX MX2014002909A patent/MX351641B/es active IP Right Grant
- 2012-09-12 ES ES12832223T patent/ES2753234T3/es active Active
- 2012-09-12 WO PCT/US2012/054928 patent/WO2013040080A1/en active Application Filing
- 2012-09-12 SG SG11201502833RA patent/SG11201502833RA/en unknown
- 2012-09-12 EP EP19191616.2A patent/EP3597212B1/en active Active
- 2012-09-12 CN CN201280044207.8A patent/CN104023741B/zh active Active
-
2014
- 2014-03-11 IL IL231454A patent/IL231454B/en active IP Right Grant
- 2014-03-11 CR CR20140119A patent/CR20140119A/es unknown
-
2015
- 2015-01-22 HK HK15100708.6A patent/HK1200319A1/xx unknown
-
2016
- 2016-07-12 US US15/208,280 patent/US20160317703A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP2755676A1 (en) | 2014-07-23 |
HK1200319A1 (en) | 2015-08-07 |
US20160317703A1 (en) | 2016-11-03 |
EP3597212A1 (en) | 2020-01-22 |
EP3597212B1 (en) | 2022-05-11 |
CN104023741A (zh) | 2014-09-03 |
WO2013040080A1 (en) | 2013-03-21 |
BR112014005597B1 (pt) | 2019-10-15 |
EP2755676A4 (en) | 2015-06-03 |
EP2755676B1 (en) | 2019-08-14 |
US20150079152A1 (en) | 2015-03-19 |
MX351641B (es) | 2017-10-23 |
ES2753234T3 (es) | 2020-04-07 |
CR20140119A (es) | 2014-07-11 |
CA2848351A1 (en) | 2013-03-21 |
US9408913B2 (en) | 2016-08-09 |
BR112014005597A2 (pt) | 2017-04-04 |
MX2014002909A (es) | 2014-11-25 |
CN104023741B (zh) | 2017-11-17 |
IL231454B (en) | 2021-06-30 |
SG11201502833RA (en) | 2015-05-28 |
IL231454A0 (en) | 2014-04-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CR20190006A (es) | Composición y aposito para tratamiento de heridas | |
CY1122480T1 (el) | Μεθυλικη βαρδοξολονη για τη θεραπεια παχυσαρκιας | |
BR112014000665A2 (pt) | composto, uso do mesmo, composição farmacêutica, agente antimicrobiano, e, método para previnir ou tratar uma infecção bacteriana | |
BR112015027704A2 (pt) | Composto, uso do mesmo e composição farmacêutica antibacteriana | |
EA201692487A1 (ru) | Ингибиторы фосфатидилинозитол-3-киназы | |
BR112014021104A2 (pt) | métodos e composições para o tratamento da doença de huntington | |
SV2009003307A (es) | Quinazolinas para la inhibicion de pdk1 | |
NI201300101A (es) | Modulación de la expresión del transductor de señales y activador de la transcripción 3 (stat3) | |
CR20140229A (es) | Nuevos derivados bicíclicos de dihidroisoquinolin-1-ona | |
CY1123056T1 (el) | Νεα μορφη χορηγησης της ρασεκαδοτριλης | |
DK3251678T3 (da) | Benzoxaborolderivater til behandling af bakterieinfektioner | |
EA201391072A1 (ru) | Производные фтор-пиридинона, полезные в качестве антибактериальных агентов | |
EA201200098A1 (ru) | Конденсированные имидазолы и содержащие их композиции, предназначенные для лечения паразитарных заболеваний, таких как, например, малярия | |
EA201370071A1 (ru) | Способы и композиции для лечения рака легких | |
CL2015002346A1 (es) | Estra-1,3,5(10),16-tetraeno-3-carboxamidas para la inhibicion de la 17b-hidroxiesteroide deshidrogenasa (akr1 c3) | |
CL2012002716A1 (es) | Uso de un compuesto inhibidores de dgat1 porque es útil en la prevención, demora del progreso o el tratamiento de una enfermedad o condición seleccionada a partir de quilomicronemia, síndrome de quilomicronemia familiar e hiperlipoproteinemia tipo v; un compuesto derivado de heteroarilo sustituido; composición farmacéutica. | |
EA201490688A1 (ru) | 2-тиопиримидиноны | |
CY1120877T1 (el) | Συνθεσεις και μεθοδοι για την αντιμετωπιση της κοιλιοκακης | |
ECSP13012893A (es) | Ureas asimétricas y usos médicos de las mismas | |
BR112013010136A2 (pt) | vacina, composição terapêutica e métodos para o tratamento ou inibição de gliblastoma | |
CO7240418A2 (es) | Apósito con una liberación prolongada de agentes activos | |
BR112013024951A2 (pt) | método de tratamento de tecidos biológicos, membranas ou outras estruturas, e, composição para a coloração de tecidos biológicos, membranas ou outras estruturas | |
CY1117414T1 (el) | Παραγοντες αναστροφης αντιπηκτικου | |
UA107346C2 (en) | Use of nifuratel to treat infections caused by atopobium species | |
BR112014005788A2 (pt) | variante de antitripsina alfa-1, método de preparação da mesma e aplicação da mesma |